IMRX
USDImmuneering Corporation Class A Common Stock
$6.380+0.170 (2.738%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$6.210
High
$6.730
Low
$6.150
Volume
0.05M
Company Fundamentals
Market Cap
403.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.87M
Exchange
NGM
Currency
USD
52-Week Range
Low $1.1Current $6.380High $10.08
Related News
GlobeNewswire
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
- New case studies on first-line pancreatic cancer patients treated with atebimetinib in combination with FOLFIRINOX to be shared by trial investigators – - Conference call scheduled for Wednesday, November 12, 2025, at
View more
Analyst Upgrades
Leerink Partners Initiates Coverage On Immuneering with Outperform Rating, Announces Price Target of $15
Leerink Partners analyst Andrew Berens initiates coverage on Immuneering with a Outperform rating and announces Price Target of $15.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.